Literature DB >> 2977469

Gastroschisis: prenatal diagnosis and management.

H Grundy1, R L Anderson, R A Filly, P Callen, J D Goldberg, R N Slotnick, M S Golbus.   

Abstract

Ten fetuses with gastroschisis on whom a prenatal sonographic diagnosis and evaluation were available and who delivered at the University of California, San Francisco, were evaluated retrospectively. Six fetuses were delivered vaginally without mortality and minimal or absent morbidity. Four were delivered abdominally, 2 for unrelated obstetrical indications. A 3rd fetus had a suspected prenatal bowel perforation and was the sole mortality. Only 1 mother underwent primary cesarean section, specifically due to the fetal gastroschisis. Umbilical cord pH values were normal in those delivered vaginally. With careful ultrasound examination and immediate neonatal surgical capability in a level III perinatal center, vaginal delivery of fetuses with gastroschisis can be associated with excellent outcome. A multinational randomized study of the delivery mode of fetuses with gastroschisis is necessary and appropriate at this time.

Entities:  

Mesh:

Year:  1987        PMID: 2977469     DOI: 10.1159/000263308

Source DB:  PubMed          Journal:  Fetal Ther        ISSN: 0257-2788


  2 in total

1.  Mode of delivery and mortality among neonates with gastroschisis: A population-based cohort in Texas.

Authors:  Adriana Lopez; Renata H Benjamin; Janhavi R Raut; Anushuya Ramakrishnan; Laura E Mitchell; Kuojen Tsao; Anthony Johnson; Peter H Langlois; Michael D Swartz; A J Agopian
Journal:  Paediatr Perinat Epidemiol       Date:  2019-05-14       Impact factor: 3.980

2.  The influence of gestational age, mode of delivery and abdominal wall closure method on the surgical outcome of neonates with uncomplicated gastroschisis.

Authors:  Maria V Fraga; Pablo Laje; William H Peranteau; Holly L Hedrick; Nahla Khalek; Juliana S Gebb; Julie S Moldenhauer; Mark P Johnson; Alan W Flake; N Scott Adzick
Journal:  Pediatr Surg Int       Date:  2018-02-07       Impact factor: 1.827

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.